CA
4
-8
FITB
55
3
XYL
52
3
LB
56
11
SIG
52
5
MDLZ
30
2
MKC
56
2
GILD
58
2
HIG
70
4
C
58
3
COST
53
3
SCHW
40
7
RF
45
4
DUK
42
-3
BXP
57
3
FCX
62
5
LYB
60
7
NEM
36
2
COF
59
6
MET
64
7
CA
4
-8
FITB
55
3
XYL
52
3
LB
56
11
SIG
52
5
MDLZ
30
2
MKC
56
2
GILD
58
2
HIG
70
4
C
58
3
COST
53
3
SCHW
40
7
RF
45
4
DUK
42
-3
BXP
57
3
FCX
62
5
LYB
60
7
NEM
36
2
COF
59
6
MET
64
7
Financhill
Back

Sarepta Therapeutics Vs. Smith-Midland Industry Stock Comparison

Sell
26

SRPT
Sarepta Therapeutics

Last Price:
117.76
Seasonality Move:
-0.82%
Sell
35

SMID
Smith-Midland

Last Price:
33.45
Seasonality Move:
15.33%
Sell
26
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $120.40. The Score for SRPT is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
35
Smith-Midland (SMID) is a Sell

Is Smith-Midland a Buy, Sell or Hold?

  • The current Smith-Midland [SMID] share price is $32.62. The Score for SMID is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • SMID is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $120.40
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing slight buying pressure.

SMID Stock Price Chart

What is Smith-Midland's stock price today?

  • The Smith-Midland share price today is $32.62
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SMID is experiencing buying pressure, which is a positive indicator for future bullish movement.

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.41 Sell
Relative Strength Index (14 RSI): 32.45 Sell
Chaikin Money Flow: 79309 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (122.31 - 130.81) Sell
Bollinger Bands (100): (122.97 - 147.31) Sell

SMID Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.2 Sell
Relative Strength Index (14 RSI): 47.04 Sell
Chaikin Money Flow: 8445 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (31.13 - 35.93) Sell
Bollinger Bands (100): (29.59 - 35.83) Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 122.86 Sell
20-day SMA: 124.78 Sell
50-day SMA: 132.71 Sell
200-day SMA: 128.28 Sell
8-day EMA: 122.39 Sell
20-day EMA: 125.48 Sell
50-day EMA: 130.61 Sell
200-day EMA: 128.3 Sell

SMID Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 32.81 Sell
20-day SMA: 33.96 Sell
50-day SMA: 32.8 Sell
200-day SMA: 36.34 Sell
8-day EMA: 32.79 Sell
20-day EMA: 33.42 Sell
50-day EMA: 33.14 Sell
200-day EMA: 32.96 Sell

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.81 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.41 per share, and an increase next year of $9.14 per share.

Smith-Midland Earnings Growth & SMID Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Smith-Midland Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):